Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · IEX Real-Time Price · USD
8.03
-0.05 (-0.68%)
Apr 26, 2024, 10:50 AM EDT - Market open
Ironwood Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 442.74 | 410.6 | 413.75 | 389.52 | 428.41 | 346.64 | 298.28 | 273.96 | 149.56 | 76.44 | Upgrade
|
Revenue Growth (YoY) | 7.83% | -0.76% | 6.22% | -9.08% | 23.59% | 16.21% | 8.88% | 83.18% | 95.66% | 234.06% | Upgrade
|
Cost of Revenue | 0 | 0 | 0 | 3.14 | 23.88 | 33 | 19.41 | 2.24 | 17.65 | 25.58 | Upgrade
|
Gross Profit | 442.74 | 410.6 | 413.75 | 386.39 | 404.54 | 313.64 | 278.87 | 271.72 | 131.91 | 50.85 | Upgrade
|
Selling, General & Admin | 158.31 | 115.99 | 111.13 | 140 | 172.45 | 219.68 | 231.18 | 173.28 | 125.25 | 118.33 | Upgrade
|
Research & Development | 116.09 | 44.27 | 70.41 | 88.06 | 115.04 | 101.06 | 88.15 | 139.49 | 108.75 | 101.89 | Upgrade
|
Other Operating Expenses | 1,114 | 0 | -0.04 | 15.38 | -3.08 | 174.62 | 6.21 | 0.98 | 0 | 0 | Upgrade
|
Operating Expenses | 1,388 | 160.26 | 181.49 | 243.45 | 284.42 | 495.36 | 325.54 | 313.75 | 233.99 | 220.22 | Upgrade
|
Operating Income | -945.43 | 250.34 | 232.26 | 142.94 | 120.12 | -181.72 | -46.67 | -42.04 | -102.09 | -169.37 | Upgrade
|
Interest Expense / Income | 21.63 | 7.6 | 31.15 | 29.48 | 36.6 | 37.72 | 36.37 | 39.15 | 31.1 | 21.17 | Upgrade
|
Other Expense / Income | -48.31 | -9.68 | 0.45 | 4.6 | 62.02 | 62.93 | 33.89 | 0.52 | 9.49 | -0.92 | Upgrade
|
Pretax Income | -918.75 | 252.42 | 200.66 | 108.86 | 21.51 | -282.37 | -116.94 | -81.71 | -142.67 | -189.62 | Upgrade
|
Income Tax | 83.49 | 77.36 | -327.79 | 2.69 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Net Income | -1,002.24 | 175.07 | 528.45 | 106.18 | 21.51 | -282.37 | -116.94 | -81.71 | -142.67 | -189.62 | Upgrade
|
Net Income Growth | - | -66.87% | 397.71% | 393.73% | - | - | - | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 155 | 154 | 162 | 159 | 156 | 153 | 149 | 145 | 142 | 137 | Upgrade
|
Shares Outstanding (Diluted) | 155 | 186 | 164 | 161 | 156 | 153 | 149 | 145 | 142 | 137 | Upgrade
|
Shares Change | -16.57% | 13.32% | 2.34% | 2.97% | 2.22% | 2.44% | 2.80% | 1.95% | 3.91% | 18.09% | Upgrade
|
EPS (Basic) | -6.45 | 1.13 | 3.26 | 0.67 | 0.14 | -1.85 | -0.78 | -0.56 | -1.00 | -1.39 | Upgrade
|
EPS (Diluted) | -6.45 | 0.96 | 3.21 | 0.66 | 0.14 | -1.85 | -0.78 | -0.56 | -1.00 | -1.39 | Upgrade
|
EPS Growth | - | -70.09% | 386.36% | 371.43% | - | - | - | - | - | - | Upgrade
|
Free Cash Flow | 183.15 | 273.63 | 261.63 | 166.99 | 3.8 | -69.67 | -103.42 | -29.92 | -110.83 | -159.11 | Upgrade
|
Free Cash Flow Per Share | 1.18 | 1.77 | 1.61 | 1.05 | 0.02 | -0.46 | -0.69 | -0.21 | -0.78 | -1.16 | Upgrade
|
Gross Margin | 100.00% | 100.00% | 100.00% | 99.19% | 94.43% | 90.48% | 93.49% | 99.18% | 88.20% | 66.53% | Upgrade
|
Operating Margin | -213.54% | 60.97% | 56.13% | 36.70% | 28.04% | -52.42% | -15.65% | -15.35% | -68.26% | -221.58% | Upgrade
|
Profit Margin | -226.37% | 42.64% | 127.72% | 27.26% | 5.02% | -81.46% | -39.20% | -29.83% | -95.40% | -248.07% | Upgrade
|
Free Cash Flow Margin | 41.37% | 66.64% | 63.23% | 42.87% | 0.89% | -20.10% | -34.67% | -10.92% | -74.11% | -208.16% | Upgrade
|
Effective Tax Rate | - | 30.65% | -163.36% | 2.47% | - | - | - | - | - | - | Upgrade
|
EBITDA | -895.55 | 261.44 | 233.33 | 141.9 | 63.69 | -232.67 | -67.91 | -31.3 | -99.94 | -156.12 | Upgrade
|
EBITDA Margin | -202.28% | 63.67% | 56.39% | 36.43% | 14.87% | -67.12% | -22.77% | -11.42% | -66.83% | -204.25% | Upgrade
|
Depreciation & Amortization | 1.58 | 1.42 | 1.52 | 3.56 | 5.58 | 11.97 | 12.66 | 11.26 | 11.63 | 12.33 | Upgrade
|
EBIT | -897.12 | 260.02 | 231.81 | 138.34 | 58.11 | -244.64 | -80.57 | -42.56 | -111.57 | -168.45 | Upgrade
|
EBIT Margin | -202.63% | 63.33% | 56.03% | 35.51% | 13.56% | -70.58% | -27.01% | -15.53% | -74.60% | -220.38% | Upgrade
|